Next Article in Journal
The Adipocyte–Macrophage Relationship in Cancer: A Potential Target for Antioxidant Therapy
Next Article in Special Issue
Beyond Antioxidant Activity: Redox Properties of Catechins May Affect Changes in the DNA Methylation Profile—The Example of SRXN1 Gene
Previous Article in Journal
Genistein Promotes Anti-Heat Stress and Antioxidant Effects via the Coordinated Regulation of IIS, HSP, MAPK, DR, and Mitochondrial Pathways in Caenorhabditis elegans
Previous Article in Special Issue
Role of Phosphoinositide 3-Kinase in Regulation of NOX-Derived Reactive Oxygen Species in Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Reduced Ribose-5-Phosphate Isomerase A-1 Expression in Specific Neurons and Time Points Promotes Longevity in Caenorhabditis elegans

1
Institute of Biotechnology, National Tsing Hua University, HsinChu 300044, Taiwan
2
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Mioali Country 35053, Taiwan
3
Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan
4
Department of Cardiology, Chang Gung Memory Hospital, Linkou Main Branch, Chang Gung University, Taoyuan 33305, Taiwan
5
Department of Life Science, National Tsing Hua University, HsinChu 300044, Taiwan
*
Author to whom correspondence should be addressed.
Antioxidants 2023, 12(1), 124; https://doi.org/10.3390/antiox12010124
Submission received: 14 November 2022 / Revised: 30 December 2022 / Accepted: 31 December 2022 / Published: 4 January 2023
(This article belongs to the Special Issue Something is Rotten in the State of Redox)

Abstract

:
Deregulation of redox homeostasis is often associated with an accelerated aging process. Ribose-5-phosphate isomerase A (RPIA) mediates redox homeostasis in the pentose phosphate pathway (PPP). Our previous study demonstrated that Rpi knockdown boosts the healthspan in Drosophila. However, whether the knockdown of rpia-1, the Rpi ortholog in Caenorhabditis elegans, can improve the healthspan in C. elegans remains unknown. Here, we report that spatially and temporally limited knockdown of rpia-1 prolongs lifespan and improves the healthspan in C. elegans, reflecting the evolutionarily conserved phenotypes observed in Drosophila. Ubiquitous and pan-neuronal knockdown of rpia-1 both enhance tolerance to oxidative stress, reduce polyglutamine aggregation, and improve the deteriorated body bending rate caused by polyglutamine aggregation. Additionally, rpia-1 knockdown temporally in the post-developmental stage and spatially in the neuron display enhanced lifespan. Specifically, rpia-1 knockdown in glutamatergic or cholinergic neurons is sufficient to increase lifespan. Importantly, the lifespan extension by rpia-1 knockdown requires the activation of autophagy and AMPK pathways and reduced TOR signaling. Moreover, the RNA-seq data support our experimental findings and reveal potential novel downstream targets. Together, our data disclose the specific spatial and temporal conditions and the molecular mechanisms for rpia-1 knockdown-mediated longevity in C. elegans. These findings may help the understanding and improvement of longevity in humans.

Graphical Abstract

1. Introduction

Aging is the main process leading to numerous aging-associated diseases, such as neurodegeneration diseases, diabetes, muscular dystrophy, and cancer in elder people [1,2]. Due to the dramatic increment in the elder population, research focusing on the aging process has been increasing. Environmental and physiological interventions, including dietary restriction and reduced temperature or oxygen levels, have been associated with lifespan extension across species. These interventions have been reported to trigger several downstream molecular mechanisms and eventually improve longevity [3].
Among these interventions, dietary restriction, which has prolongevity effects conserved in many species, may broadly affect the numerous downstream molecular mechanisms, including AMP activated protein kinase (AMPK) and target of rapamycin (TOR) signaling pathways [4]. AMPK and TOR pathways are highly associated with nutrient absorption, energy status, and homeostasis [5,6,7]. Previous studies have shown that nutrient deprivation triggers the activation of AMPK and inhibition of the TOR pathway; the synergistic effect of these pathways leads to the induction of the autophagy process and consequently extends lifespan across species [8]. Autophagy is a key process to maintaining cellular homeostasis, whereas failure in autophagic flux perturbs the metabolic balance and exacerbates the aging process [9,10]. It was well reported that the induction of the autophagic flux improves the lifespan in Drosophila and Caenorhabditis elegans [11,12].
On the other hand, the regulation of redox homeostasis also acts as a key factor in longevity. The redox theory of aging elucidates the relationship between oxidative stress and aging [13]. Moreover, the underlying mechanisms of how redox homeostasis regulates longevity are also well documented [14,15]. The regulation of redox homeostasis includes different defense mechanisms to remove free radicals, such as enzymatic or non-enzymatic antioxidants [16]. These enzymatic antioxidants mainly use nicotinamide adenine dinucleotide phosphate (NADPH), which is primarily produced by the oxidative phase of the pentose phosphate pathway (PPP) [17], as a reducing agent to remove free radicals. Thus, current studies have linked aging with the oxidative phase of PPP since NADPH has been reported to protect species from redox stress, improve oxidative stress tolerance, and extend lifespan [18]. Several approaches to increase NADPH levels, such as the overexpression of glucose-6-phosphate dehydrogenase (G6PD), NADPH-generating cytoplasmic malic enzyme (Men), or the knockdown of ribose-5-phosphate isomerase (Rpi), are all able to extend the lifespan in Drosophila [19,20,21,22].
Ribose-5-phosphate isomerase A (RPIA), which is the ortholog of rpia-1 in C. elegans, acts as a rate-limiting enzyme in the pentose phosphate pathway (PPP). Previously, we invented an efficient method to identify the longevity genes in Drosophila [23]. Extended by this approach, we identified and demonstrated that reduction in Rpi, the Drosophila ortholog of rpia-1 causes lifespan extension and improves healthspan by inducing G6PD activity and elevating NADPH levels to cope with oxidative stress and attenuating polyglutamine toxicity in Drosophila [22]. However, whether these phenotypical changes are evolutionarily conserved or not remains unknown. We used C. elegans as a model to investigate these phenotypical changes upon rpia-1 knockdown. Activated autophagy is a well-known longevity-associated mechanism [10]. We and another group revealed that the knockdown of RPIA in human cancer cells induces autophagy [24,25]. Hence, we also ask if autophagy induction may contribute to rpia-1-mediated lifespan regulation in C. elegans.
In this study, we reported that ubiquitous and pan-neuronal knockdown of rpia-1 result in higher NADPH levels, elevated tolerance to oxidative stress, ameliorated polyglutamine toxicity, and lifespan extension, indicating that rpia-1 knockdown-mediated longevity and related phenotypical changes may be evolutionarily conserved. In addition, we identified neurons as the target tissue and the young adult stage as the optimal timing for the extended longevity upon rpia-1 knockdown. Mechanistically, we disclosed that rpia-1 knockdown-mediated longevity requires the induction of autophagy as well as AMPK activation and TOR inhibition. Furthermore, RNA-seq analysis not only supports our experimental findings but also uncovers more potential downstream target genes, which might be involved in the lifespan regulation upon rpia-1 knockdown. Together, our results reveal the comprehensive information and molecular mechanisms of how modulation of rpia-1 regulates longevity and related phenotypes. Those novel findings may advance longevity research to benefit the human lifespan and healthspan.

2. Materials and Methods

2.1. Strains and Cultivation Conditions

All C. elegans strains were cultivated under standard conditions and as described previously [26,27]. The worms were grown at 20 °C on solid nematode growth medium (NGM) agar seeded with Escherichia coli (OP50). The following strains were used in this study: N2, wild type (Bristol); AM101, rmIs110 [F25B3.3p::Q40::YFP]; TU3401, uIs69 [pCFJ90 (myo-2p::mCherry) + unc-119p::sid-1]; WM118, neIs9 [myo-3::HA::RDE-1 + rol-6(su1006)]; VP303, kbIs7 [nhx-2p::rde-1 + rol-6(su1006)]; NR222, kzIs9 [(pKK1260) lin-26p::NLS::GFP + (pKK1253) lin-26p::rde-1 + rol-6(su1006)]; XE1582, wpSi11 [eat-4p::rde-1::SL2::sid-1 + Cbr-unc-119(+)]; XE1581, wpSi10 [unc-17p::rde-1::SL2::sid-1 + Cbr-unc-119(+)]; XE1375, wpSi1 [unc-47p::rde-1::SL2::sid-1 + Cbr-unc-119(+)]; XE1474, wpSi6 [dat-1p::rde-1::SL2::sid-1 + Cbr-unc-119(+)]; TG38, aak-2 (gt33); RB1206, rsks-1 (ok1255). CRISPR knockout strains rpia-1 (tm7117) and rpia-1 (tm6850) were outcrossed to N2 wild type animals three times before conducting the experiments. All nematodes were synchronized by bleach and were incubated in M9 buffer without food overnight.

2.2. RNA Interference

All RNAi experiments described in this article were induced by feeding assay and as described previously [27,28,29]. Worms were exposed to dsRNA producing E. coli HT115 (DE3) strain, which can be induced by isopropyl β-d-1-thiogalactopyranoside (IPTG), starting at the embryonic stage (whole life treatment) or post-developmental stage (adult-only treatment) on solid RNAi plates. The RNAi plates contained 100 μg/mL ampicillin, 10 μg/mL tetracycline, and 1 mM IPTG. RNAi-containing bacteria were grown overnight in LB broth containing 100 μg/mL ampicillin and 10 μg/mL tetracycline at 37 °C. After the overnight incubation, RNAi bacteria were inoculated into new tubes, and dsRNA production was induced by 1 mM IPTG addition. Once the bacteria grew to OD 0.6, they were spread onto the agar plates and left in the hood overnight. These RNAi plates were stored at 4 °C and were used within 2 weeks to ensure knockdown efficiency. The RNAi plasmids were verified by DNA sequencing.

2.3. Oxidative Stress Assay

The oxidative stress assay was performed using the protocol proposed by Senchuk et al. [30]. Oxidative stress was induced by 40 mM paraquat (1,1-dimethyl-4,4-bipyridinium dichloride, Sigma-Aldrich, 856177, St. Louis, MO, USA) treatment. Worms were cultivated and synchronized by the bleach assay at 20 °C. Day-0-adult (young adult) worms were transferred onto RNAi plates containing 40 mM paraquat, and dead worms were counted at 0, 15, 19, 23, 27, 39, 43, 47, 51, and 63 h until all worms died. OASIS 2 was used to perform statistical analyses and the p-value was calculated by log-rank test.

2.4. Quantification of NADP+ and NADPH Levels

The NADP+ and NADPH levels were measured by using an NADP/NADPH-Glo™ Assay (Promega, G9081, Madison, WI, USA) following the manufacturer’s protocol. Moderate amounts of samples collected in 1.5 mL microcentrifuge tubes were homogenized using a base solution (PBS, 0.2 N NaOH, and 1% SDS). Homogenized samples were transferred to a white-walled 96-well ELISA plate (50 μL per well; two wells per sample). One well of each sample was treated with 25 μL of 0.4 N HCl to measure NADP+ levels, and the other was treated with base to measure NADPH levels. After incubating for 15 min, the plate was incubated at room temperature, and HCl/Trizma® solution was added. After incubating the plate at room temperature for 30–60 min, the NADP+ and NADPH levels were measured by a luminometer. The definite concentrations of NADP+ and NADPH were calculated by a standard curve and normalized to protein concentration.

2.5. Lifespan Assay

Before conducting the lifespan assay, all parent worms were cultivated until the day-1-adult stage on solid NGM plates seeded with OP50. At least 100 worms were exposed to bleach buffer and eggs extracted from parents were stored at 18 °C overnight for synchronization as described previously [27,29]. At stage L4 (day 0 of the experiment), the worms were transferred to new plates to start the lifespan assay. Each plate contained 30 worms and the whole experiment was performed at 20 °C. For the first seven days, the worms were transferred every day to separate adults from larvae, and the numbers of censored and dead worms were recorded. After day 7, the worms were transferred and counted every 2 days until all worms died. OASIS 2 was used to perform statistical analyses and the p-value was calculated by log-rank test.

2.6. Polyglutamine Toxicity

Nematode strain AM101 was used to validate neuronal polyglutamine toxicity. For image analysis, we anesthetized worms using 10 mM sodium azide (NaN3) in M9 and mounted the animals on 2% agarose pads dissolved in M9. All worms were grown to the day-5-adult stage, and 10 worms were randomly picked to perform the experiments in triplicates. All magnified neuron images were taken using a ZEISS LSM 800 confocal microscope with a 40x objective; GFP fluorescence quantification was performed with NIS-Elements software. GFP puncta were detected automatically by the software, and statistical analyses were conducted using Prism 8.0.
Body bending assay was conducted on synchronized day-1-adult and day-7-adult stages at 20 °C. Body bending rate was defined as the bending counts of a single worm in 30 s. Each worm was placed in one droplet of M9 and allowed to recover for 1 min. After the recovery, body bends were counted for 30 s by observation. All experiments included 30 animals and were conducted in triplicates. Statistical analyses were performed by using Prism 8.0.

2.7. RNA Isolation and Reverse Transcription Followed by Quantitative PCR (RT-qPCR)

At least 500 animals were washed with M9 buffer and lysed in 500 μL Trizol Reagent (APOLO) via standard RNA extraction protocol. The extracted RNA was reverse-transcribed through Reverse Transcription System (Promega, #A3500). We diluted cDNA in a ratio of 1:9 with ddH2O to perform quantitative PCR (qPCR) by StepOne Plus Real-time PCR system (Applied Biosystems, cat # 4,376,600, Whaltam, MA, USA) with Fast SYBR™ Green Master Mix (Applied Biosystems, #4385612). The expression levels were determined by the ΔΔCt method and normalized to act-1 expression levels. All experiments were independently conducted in triplicates and statistical analyses were performed by Prism 8.0 with an unpaired t-test.
The following primers were used: rpia-1, forward 5′-GTG ACA GAC AAT GGA AAC TTC A-3′, and reverse 5′-ACG CAA CCG ATG AAT AAT CC-3′; act-1, forward 5′-ACG ACG AGT CCG GCC CAT CC-3′, and reverse 5′-GAA AGC TGG TGG TGA CGA TGG TT-3′; lgg-1, forward 5′-ACC CAG ACC GTA TTC CAG TG-3′, and reverse 5′-ACG AAG TTG GAT GCG TTT TC-3′; sqst-1, forward 5′-TGG CTG CTG CAT CAT CCG CT-3′, and reverse 5′-TCA ATC GTG CCG AGA CCG GG-3′.

2.8. Protein Extraction and Western Blotting

At least 500–1000 worms were collected and homogenized with whole-cell extract (WCE) lysis buffer (20 mM HEPES [pH 7.5], 75 mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.5% Triton X-100, 0.1 mM Na3VO4, 50 mM NaF, protease inhibitor and phosphatase inhibitor), and tetragonal zirconium polycrystal (TZP). Protein extracts were centrifuged at 13,200 rpm for 20 min, and the supernatants were collected. Protein concentration was determined using Bradford assay (Bio-Rad, #5000001, Hercules, CA, USA). After denaturing at 100 °C, the protein samples were run on 10% or 14% polyacrylamide-tris gels (30 μg per well) and transferred onto nitrocellulose (NC) membranes. The membranes were blocked in 5% skim milk or BSA in TBST and incubated with following the antibodies overnight: anti-LC3B (1:1000 in 3% milk in TBST; Novus, St. Charles, MO, USA, #NB100-2220), anti-Ref2P (SQST-1) (1:1000 in 3% milk in TBST; Abcam, Cambrigde, UK, #ab178440), anti-phospho-AMPK (1:1000 in 3% BSA in TBST; Cell Signaling, Danvers, MA, USA, #2535), anti-phospho-S6K (1:1000 in 3% BSA in TBST; Cell Signaling, #9209), anti-beta actin (1:4000 in 3% milk in TBST; GeneTex, #GTX109639). Incubations with the secondary antibody Peroxidase AffiniPure Goat Anti-Rabbit IgG (H+L) (1:10,000 or 1:20,000 diluted in TBST; Jackson Immuno, t# 111-035-003) were performed for 1 h at room temperature. After washing the membranes with TBST three times, the protein bands were detected using ECL.

2.9. RNA-Seq Analysis

Samples were collected independently in triplicates, and each sample contained at least 500 worms, which were transferred to new plates every day until the day-5-adult stage. RNA was extracted using RNeasy Kit (Qiagen, #74004). The RNA-seq procedure was conducted by Taiwan Genomics Industry Alliance (TGIA) using 0.1–5 μg of total RNA. Libraries were pooled and sequenced (paired-end, 150 bp) on an Illumina NovaSeq 6000 System.

2.10. Developmental Delay Screening

Following a previously proposed protocol [31], we randomly picked five parent worms and split-bleached them onto unseeded solid NGM plates and synchronized the offspring overnight at 20 °C. The synchronized L1 larvae were transferred to bacteria-seeded plates and incubated at 20 °C for 55 h. At this time point, the number of worms at different development stages was counted. Statistical analyses were conducted by using Prism 8.0.

2.11. Generation of rpia-1 Overexpression Construct

The promoter and full-length sequences of rpia-1 were amplified from N2 genomic DNA and cloned into the L3691 plasmid to create the rpia-1 overexpression construct. The microinjection procedure was conducted by the C. elegans Core Facility (CECF). Except for the control and overexpression plasmids, the myo-2p::tdTomato plasmid was co-injected as the co-injection marker. At least two independent lines were isolated to obtain stable clones.
The following primers were used: rpia-1 promoter, forward 5′-ATA TGA GCT CCA ACT GTG TCA CTT CTC TTG TTT C-3′ (SacI), and reverse 5′-AGA GAC CGG TTC TGG CGG TTC GCA ATA C-3′ (AgeI); rpia-1 overexpression, forward 5′-ATA TGA GCT CCA ACT GTG TCA CTT CTC TTG TTT C-3′ (SacI), and reverse 5′-AGA GAC CGG TGT GCT TCT TGG AAT TGA CAA TTT C-3′ (AgeI).

3. Results

3.1. Knockdown of rpia-1 Exhibits Increased Tolerance to Oxidative Stress, Elevated Levels of NADPH, and Attenuated Polyglutamine Toxicity in C. elegans

Down-regulation of ribose-5-phosphate isomerase has been shown in Drosophila to induce several longevity-associated phenotypes, such as increased tolerance to oxidative stress, elevated levels of NADPH, and alleviated polyglutamine toxicity in neurons [22]. However, whether these effects are evolutionarily conserved remains unclear. Therefore, by utilizing C. elegans as another model organism and knocking down rpia-1, the ortholog of ribose-5-phosphate isomerase A in C. elegans, we examined whether the effects of rpia-1 knockdown from the embryonic stage throughout adulthood (named as whole life (WL) knockdown in this study) in C. elegans are conserved as those in Drosophila. Similar to our previous findings in Drosophila, we observed an elevated tolerance to paraquat-induced oxidative stress ranging from 22.3% to 32.7% in rpia-1 knockdown N2 worms compared to the wild-type N2 with the empty vector (EV) as the control (Figure 1A,B). According to the results in our previous Drosophila study, the reduction in Rpi in neurons showed a similar effect as in the Rpi mutant with ubiquitous Rpi down-regulation [22], we next asked if the enhanced rpia-1 knockdown in neurons also contributes to oxidative stress resistance. Thus, we conducted an rpia-1 reduction in the neuron-enhanced strain TU3401 and found similar results to those from an rpia-1 ubiquitous knockdown in N2. The results revealed that the knockdown of rpia-1 in the neuron-enhanced strain TU3401 promoted oxidative stress tolerance with an increase ranging from 12.7% to 14.5% compared with the controls (Figure 1C,D). Previous studies have reported that NADPH levels are often increased with the improvement in oxidative stress tolerance due to its involvement in antioxidative systems [32,33]. Consistently, we detected that both ubiquitous and pan-neuronal knockdown of rpia-1 elevated the levels of NADPH (~1.5-fold) but not those of NADP+ (Figure 1E,F). Taken together, these results indicate that the knockdown of rpia-1 improves oxidative stress tolerance and increases NADPH levels in C. elegans, similar to those in Drosophila.
Polyglutamine (polyQ) aggregation induces oxidative stress by elevating the levels of free radicals and eventually causes damage in the nervous system to trigger neurodegeneration [34]. In addition, the inhibition of NADPH oxidase, which reduces the catalysis of NADPH, ameliorates 43Q protein-induced mitochondrial dysfunction [35,36], implying that elevation of NADPH levels ameliorates polyglutamine-induced neuron toxicity. As we previously reported that the knockdown of Rpi increases NADPH levels and alleviates polyglutamine-induced toxicity in Drosophila neurons, we next asked whether the knockdown of rpia-1 can also attenuate polyglutamine-induced neuronal toxicity in C. elegans and conducted an rpia-1 knockdown at two different time points to confirm if the delayed reduction of rpia-1 can also ameliorate the deterioration in the AM101 strain, which is a neuron-specific polyQ pathogenesis model. Besides the aggregation of polyQ, the previous study also provides evidence that neuronal polyQ aggregation leads to mobility decline during aging. Thus, we further examined if the rpia-1 knockdown may affect physiological changes, such as body bending rate, in AM101 [37]. The data indicated that the knockdown of rpia-1 not only reduced polyQ aggregation in nerve rings but also ameliorated the deteriorated body bending rate caused by polyQ aggregation (Figure 2A–E). Overall, these findings suggest that the knockdown of rpia-1 promotes the longevity-associated phenotypes which could be evolutionarily conserved.

3.2. Knockdown of rpia-1 in Specific Time Points and Tissues Displays Extended Lifespan

In addition to the longevity-associated phenotypes, our previous study also revealed that the down-regulation of Rpi extends the lifespan in Drosophila. Hence, we initially investigated the lifespan of the rpia-1-deficient mutant strains by utilizing the rpia-1 gene partially deleted knockout strains tm7117 and tm6850 (Figure S1A), which were generated by the National Bioresource Project in Tokyo [38]. Surprisingly, unlike the Rpi mutant flies, the rpia-1 knockout strains showed no lifespan changes compared with the N2 control (Figure S1B). Additionally, we observed that rpia-1 knockout strains exhibited a developmental delay in different stages (Figure S1C). These unexpected results may be attributed to the null expression levels of the rpia-1 knockout strains, in which the CRISPR knockout of rpia-1 produced rpia-1 loss-of-function mutations. On the contrary, the Rpi mutant in Drosophila is generated by P-element insertion resulting in a hypomorphic mutation in Rpi. Thus, the different extent of rpia-1 down-regulation may be a potential factor causing these results.
Instead of using rpia-1 knockout loss-of-function strains, we assessed the lifespan changes by using an rpia-1 RNAi knockdown. However, the knockdown of rpia-1 in the wild type N2 strain from the embryonic stage throughout adulthood (WL) did not show any lifespan change either (Figure 3A) as with the rpia-1 knockout strains (Figure S1B). This outcome may be caused by two factors: the temporal aspect and the spatial aspect. First, the phenotype of developmental delay in the rpia-1 knockout mutants implied the possibility that rpia-1 might play a role during development, whereby the reduced levels of the rpia-1 transcript during the developmental stage might negatively affect longevity. Second, our previous study revealed that the ubiquitous knockdown of Rpi in Drosophila only slightly prolongs lifespan, whereas the pan-neuronal knockdown of Rpi induces significantly high levels of lifespan extension [22]. Therefore, we further investigated whether rpia-1 knockdown in a specific time window or specific tissue may mediate lifespan extension in C. elegans.
To examine the temporal effect of rpia-1 knockdown expression and avoid the potentially detrimental effect of rpia-1 reduction in the developmental stage on lifespan, we postponed the time point of rpia-1 knockdown initiation to the post-developmental stage and measured the changes in lifespan. The time points we chose were day 0, day 5, and day 7 of adulthood. Day 0 of adulthood indicates the time point of entering the post-developmental stage, which is also known as the young adult (YA) stage. Day 5 of adulthood is the time point after the peak of reproductive development [39], which may be considered menopause in humans. Day 7 of adulthood in our experiments is usually the time when worms start to die. Our results showed that the knockdown of rpia-1 after the developmental stage in these three post-developmental time points significantly extended mean lifespan by 7.5%, 6.5%, and 3.9%, respectively (Figure 3B–D). Among these three time points, the knockdown of rpia-1 on day 0 of adulthood resulted in the largest lifespan extension (7–8%) (Figure 3E). In summary, we disclose that the lifespan extension by the rpia-1 knockdown depends on the post-developmental stage, with the maximal lifespan extension in young adult wild-type N2 worms.
To examine whether the spatial aspect of rpia-1 knockdown expression may play a role in longevity, we reduced the rpia-1 expression in certain tissues and measured the lifespan changes. Based on our finding that whole-life rpia-1 ubiquitous knockdown failed to extend lifespan, which might be affected by the spatial aspect, we conducted an rpia-1 knockdown both in the embryonic stage (WL) and on day 0 of adulthood, respectively. Owing to the fact that the pan-neuronal knockdown of Rpi dramatically prolongs the lifespan in Drosophila, we looked up the expression patterns of rpia-1 in WormBase and found that rpia-1 has been reported to be expressed in the neurons, muscles, intestine, and hypodermis. Hence, we conducted lifespan experiments in four different tissue-specific strains (Table 1). All the strains mentioned below have been used in various lifespan assays and exhibited longevity-associated phenotypes. By reducing the rpia-1 expression in these strains, we found that worms with pan-neuronal knockdown of rpia-1 exhibited the highest levels of lifespan extension (13.7%) (Figure 4A), whereas hypodermis-specific rpia-1 knockdown displayed reduced lifespan (−4.6%) (Figure 4D), yet no changes in muscle or in the intestine (Figure 4B,C). The data indicate that neurons may be at least one of the major target tissues responsible for lifespan extension upon rpia-1 knockdown in C. elegans, which is also similar to our previous finding in Drosophila.
Since the worms with pan-neuronal knockdown of rpia-1 exhibited the largest levels of lifespan extension, we wondered if the reduction in rpia-1 level in certain specific neurons is sufficient to display lifespan extension. To address this, we conducted lifespan assays in neuron cell-type-specific strains (Table 2) [44] and down-regulated rpia-1 expression from the embryonic stage (WL) and day 0 of adulthood in those strains to measure the lifespan. Our results indicated that whole-life knockdown of rpia-1 either in glutamatergic neurons in XE1582 or in cholinergic neurons in XE1581 was sufficient to extend lifespan (Figure 4E,F). In contrast, the knockdown of rpia-1 in GABAergic neurons in XE1375 or in dopaminergic neurons in XE1474 showed no effect on longevity (Figure 4G,H). Interestingly, the whole-life knockdown of rpia-1 in glutamatergic neurons in XE1582 exhibited the largest amount of mean lifespan extension (13.4%), similar to the pan-neuronal knockdown of rpia-1 in TU3401. It may imply that glutamatergic neurons could be the major target neuron cell type in the neuron tissue for lifespan extension by rpia-1 knockdown. Together, these results indicate that the knockdown of rpia-1 in glutamatergic neurons or in cholinergic neurons is sufficient to prolong the lifespan in C. elegans.

3.3. Knockdown of rpia-1 Extends Lifespan by Activating Autophagy and AMPK Pathway and by Inhibiting TOR Pathway

Recently, a positive relationship between the elevation of NADPH levels and lifespan extension has been reported [18,46]. Since NADPH is generated in the oxidative phase of the pentose phosphate pathway (PPP) [47], we previously reported that the deregulation of Rpi may constrain the process of PPP from entering the non-oxidative phase. By this limitation, the PPP may be sustained in the oxidative phase and produce more NADPH to improve longevity [22]. Indeed, we also confirmed the elevation of NADPH levels and the lifespan extension in worms by rpia-1 knockdown (Figure 1E,F and Figure 3), supporting our previous theory.
Although the balance of redox homeostasis is one of the longevity-associated factors, we asked if any other molecular mechanisms were participating in the rpia-1 knockdown-mediated longevity. We and another group showed that the down-regulation of RPIA, the human ortholog of rpia-1, activates autophagy [24,25]. Autophagy induction has been associated with lifespan and healthspan extension [9]. Thus, by following the autophagy guideline and several studies in autophagy, we designed a series of experiments to investigate the levels of autophagy-related genes in rpia-1 knockdown in the day 0 of adulthood group, since this group of worms extended lifespan the most [9,10,11,12,48,49,50]. For the investigation at the transcriptional level, we validated the mRNA expression levels of lgg-1 and sqst-1, which are two autophagy-related genes represented as markers for mid- and late-autophagy; they are orthologs of human LC3 and SQSTM1/p62, respectively [11,12]. If autophagy is induced, we may find the transcriptional levels of these genes increasing. For the translational aspect, we observed the protein expression of LGG-1/LC3 and SQST-1/SQSTM1/p62. Based on the studies in autophagy, upon induction of autophagy, the LGG-1 precursor is cleaved from the LGG-1-I unlipidated form into the LGG-1-II lipidated form to elongate the phagophores in the mid-stage of autophagy; on the other hand, SQST-1 functions as an autophagosome cargo protein which brings the targeted proteins into autophagosome to be lysed simultaneously, hence the induction of autophagy process leads to SQST-1 degradation [11,12]. From our results, we found that the reduction of rpia-1 is accompanied by the up-regulation of autophagy-related genes lgg-1 and sqst-1 at the transcriptional level (Figure 5A), and with reduced SQST-1 levels and increased LGG-1-II form levels at the translational level (Figure 5B), which both suggest that a reduction in rpia-1 is associated with activated autophagy. Next, we also conducted lifespan assays in worms with an rpia-1 knockdown from day 0 of adulthood under an autophagy-reduction background by knockdown of lgg-1. We referred to the experimental design from Kumsta et al., in which they concluded that the HSF-1-mediated lifespan extension is directly caused by autophagy induction by blocking lgg-1. To confirm whether knockdown of lgg-1 affected lifespan, they applied hormetic heat shock as a positive control, with which they proved that HSF-1 overexpression can extend lifespan by inducing autophagy priorly, and found that the knockdown of lgg-1 ablated the lifespan extension caused by HSF-1 overexpression [49]. According to their experimental design, we first confirmed that the autophagy-mediated lifespan extension caused by hormetic heat shock can be ablated by reducing lgg-1 [49] (Figure 5C, right panel). Under this premise, we then conducted lifespan assays for rpia-1 knockdown from day 0 of the adulthood group under autophagy-reducing conditions by knockdown of lgg-1. In line with our hypothesis, the lifespan extension by rpia-1 knockdown from day 0 of adulthood is blocked when autophagy was suppressed by lgg-1 knockdown (Figure 5C, left panel), indicating rpia-1 knockdown-mediated longevity requires activated autophagy. Taken together, these results suggest that knockdown of rpia-1 may extend lifespan by inducing autophagy.
According to our data and previous findings, the knockdown of rpia-1/Rpi extends lifespan associated with elevated NADPH levels in C. elegans and in Drosophila [22], and RPIA knockdown induces autophagy in human colorectal cancer cells [25]. The AMPK pathway and TOR pathway have been shown to regulate the autophagy process in previous studies [51]. These pathways not only regulate lifespan but are also involved in energy homeostasis, which may be related to NADPH generation [52]. Hence, to assess whether rpia-1 knockdown may prolong lifespan by activating AMPK and inhibiting TOR, we conducted Western blotting analyses, by detecting p-AMPK and p-S6K as the markers for AMPK and TOR pathway activity, respectively, in rpia-1 RNAi knockdown and control (EV) N2 worms. The results indicated that the knockdown of rpia-1 from day 0 of adulthood causes a two-fold increase in p-AMPK levels and a reduction in p-S6K levels by 0.75-fold (Figure 6A,C), suggesting that AMPK activation and TOR inhibition may participate in rpia-1-knockdown mediated longevity. To confirm the hypothesis, we performed the lifespan analysis for rpia-1 knockdown from day 0 of adulthood in an aak-2(gt33) deletion mutant for the AMPK pathway, for which aak-2 is the ortholog of human AMP-activated protein kinase catalytic subunit alpha ½, and in the rsks-1(ok1255) mutant for the TOR pathway, for which rsks-1 is the ortholog for human ribosomal protein S6 kinase B2, as well as in N2 as the control. The lifespan extension caused by the rpia-1 knockdown from day 0 of adulthood was blocked in the aak-2(gt33) mutant (Figure 6B), suggesting that rpia-1 knockdown-mediated longevity requires aak-2. Moreover, the longevity of rsks-1(ok1255) was not further extended upon rpia-1 knockdown (Figure 6D), indicating that rpia-1 knockdown-mediated longevity is involved in reduced TOR signaling. Together, these data support that the knockdown of rpia-1 prolongs lifespan probably through activating AMPK and inhibiting TOR pathways as well.

3.4. RNA Sequencing Analysis Reveals Potential Downstream Target Genes in rpia-1 Knockdown-Mediated Longevity Regulation

To further validate how the knockdown of rpia-1 activates these longevity-related molecular mechanisms as well as better identify the genes involved in longevity by rpia-1 knockdown, we chose the two most long-lived strains by rpia-1 knockdown according to our previous lifespan results (Figure 3 and Figure 4), which are rpia-1 RNAi knockdown strains in day-0-onset ubiquitous N2 (N2 rpia-1 (RNAi) Day 0) and in whole-life pan-neuronal TU3401 (TU3401 rpia-1 (RNAi) WL), together with their control worms for RNA sequencing (RNA-seq) and further analyses to identify the downstream genes and pathways which may lead to improved longevity by rpia-1 RNAi knockdown.
By using the Ingenuity Pathway Analysis (IPA), we found that both long-lived rpia-1 knockdown strains showed suppressed organismal death and enhanced cell viability, supporting our findings in longevity regulation (Figure S2A). Furthermore, IPA also revealed that the knockdown of rpia-1 in neurons reduces glutamate receptor signaling (Figure S2B); hyperexcitable glutamatergic neurons shorten lifespan, supporting our findings that knockdown of rpia-1 in glutamatergic neurons prolongs lifespan (Figure 4E). Consistent with our results mentioned above (Figure 5), IPA showed that both long-lived rpia-1 knockdown strains exhibited the induction of several autophagy-related bio-functions as well as the activation of the autophagy process and phagosome formation (Figure S3A,B). Moreover, besides autophagy activation, canonical pathway analysis also showed that several longevity-related pathways, such as the AMPK pathway and sirtuin signaling pathway, were induced (Figure S3B).
In addition to IPA, we also conducted an over-representation analysis (ORA), which is the most broadly applied tool in RNA-seq analysis, to validate potential downstream target genes responsible for the induction of longevity-related molecular mechanisms. Before conducting the analysis, we set the threshold of expression level difference to two-fold for filtering; if the gene expression changes did not reach the threshold for a particular gene, we considered this gene to show no differential gene expression. By comparing the filtered gene sets of long-lived rpia-1 knockdown strains, we found that 401 genes were up-regulated (Figure 7A) and 264 were down-regulated (Figure S4A). Next, we compared the gene ontology (GO) term analysis results of these 401 up-regulated and 264 down-regulated genes and identified the gene classes in each group for further analysis. We uncovered that the histone H3-K79 methylation may be an up-regulation-specific class (Figure 7B); on the other hand, fucosylation and synapse-related gene classes, which have not been reported to be associated with longevity, may be the down-regulation-specific classes (Figure S4B).
Histone H3-K79 methylation has been reported to be associated with longevity. Previous studies not only verified that the induction of H3-K79 methylation acts as a downstream process of AMPK-induced longevity, but they also revealed that the inhibition of H3-K79 methylation by inhibiting histone methyltransferases may interfere with longevity [53,54,55]. The histone methyltransferase in C. elegans is encoded by dot-1.2, which was up-regulated in the long-lived rpia-1 knockdown strains (Figure 7D). This may support our finding that the knockdown of rpia-1 mediates lifespan through activating AMPK and might trigger H3-K79 methylation by increasing dot-1.2 expression.
Along with the GO term analysis, we also conducted pathway analysis in 401 up-regulated genes and 264 down-regulated genes based on ORA. By KEGG, Panther, and Reactome pathway analyses, we found that histone genes, including his-9, his-58, and his-43, were up-regulated in long-lived rpia-1 knockdown strains (Figure 7C,E). Previous studies and our studies have demonstrated that the elevation of histone gene expression extends the lifespan in both Drosophila and C. elegans [56,57]. Moreover, the study in Drosophila mentioned that histone overexpression extends lifespan through the sirtuin signaling pathway, which also echoes our IPA results, suggesting that his-9, his-58, and his-43 might be potential downstream target genes in rpia-1 knockdown-mediated lifespan regulation. Unlike up-regulated gene sets, pathway analysis in down-regulated gene sets exhibited a weak connection to longevity. Three genes were identified by pathway analysis, including gmd-2, ZK697.8, and scl-14 (Figure S4C,D). Although gmd-2 is involved in fructose and mannose metabolism, and scl-14 is involved in the PI3 kinase pathway, they were not reported to be associated with longevity. ZK697.8 encodes the protein transthyretin, which is associated with neurodegenerative diseases and has been reported to negatively regulate lifespan in Drosophila [58]. Altogether, RNA-seq analyses not only support our results mentioned above but also uncover more potential downstream target genes worthy of further investigation.

4. Discussion

In this study, we found that the reduction in rpia-1 improves longevity, enhances oxidative stress tolerance, and alleviates neuronal polyglutamine toxicity in C. elegans. Furthermore, we provided evidence that this phenomenon of lifespan and healthspan regulation may be attributed to the elevation of NADPH levels, activation of autophagy and AMPK pathways, and inhibition of the TOR pathway (Figure 8). In addition, we confirmed that the knockdown of rpia-1 in certain spatial and temporal conditions can lead to the largest amount of lifespan extension. Although we were not able to detect lifespan extension in rpia-1 CRISPR knockout strains, our results revealed that ubiquitous knockdown of rpia-1 in the post-developmental stage prolongs lifespan. Despite our previous study showing that the Drosophila hypomorph Rpi mutant displays an extended lifespan [22], rpia-1 knockout mutants did not exhibit lifespan extension. This discrepancy may be due to the different levels of reduction in rpia-1 expression levels. As the rpia-1 knockout mutants showed developmental delay (Figure S1C), which did not occur in the Drosophila hypomorph mutant, the rpia-1 null mutation might possess a negative effect on physiological regulation during development. However, rpia-1 knockdown by feeding rpia-1 dsRNA-containing bacteria starting at the embryonic stage also failed to prolong lifespan. Thus, instead of feeding bacteria at the embryonic stage, we postponed the onset of knockdown to the post-developmental stage with the purpose of preventing rpia-1 down-regulation from affecting development. The outcome showed that the knockdown of rpia-1 after the developmental stage indeed extended lifespan, supporting our hypothesis. The correlation between PPP and development has not been established in animals, whereas PPP has been associated with cancer metabolism and cell survival [25,59,60]. Since PPP is not only involved in glucose catabolism, and the metabolites generated by this process, such as NADPH, also help in detoxifying intracellular reactive oxygen species, PPP plays vital roles in cancer development and survival [61]. A previous study in Arabidopsis reported that the dysregulation of PPP disrupts development and that ribose-5-phosphate (which is generated by RPIA) is essential in embryonic development [62]. These findings support our observation that the lack of rpia-1 during development may disrupt larvae growth and might disrupt the rpia-1-mediated longevity effect in C. elegans.
Besides the temporal aspects, spatial aspects also mattered in rpia-1-mediated longevity. Consistent with our previous findings in Drosophila [22], we also observed the highest levels of lifespan extension in worms with neuron-enhanced knockdown of rpia-1. In order to in depth examine which specific neuron cell type is the most crucial in rpia-1-mediated lifespan regulation, we conducted lifespan experiments in neuron cell-type-specific knockdown strains [44]. Intriguingly, we identified two specific cell types, glutamatergic and cholinergic neurons, which were responsible for longevity regulation. These neurons are also known as excitatory neurons, where the action potential of presynaptic neurons may increase the potential action of postsynaptic neurons. Neuron excitation consumes nearly 80–85% of the ATP generated to pass neural signals; thus, the rates of the TCA cycle and glucose oxidation, which are the major pathways to generate ATP, increase the most in excitatory neurons, especially in glutamatergic neurons [63]. Therefore, reducing rpia-1 in excitatory neurons sustains the PPP in the oxidative phase and produces fewer non-oxidative-phase metabolites, which might affect the process of excitatory neurotransmission and suppress neuron excitation. The role of excitatory neuron suppression in longevity has been reported by a previous study, where genetic inhibition of neural excitation resulted in lifespan extension in both rodents and worms [64]. Along with our experimental results, we proposed the hypothesis that the down-regulation of rpia-1 might reduce the production of energy in excitatory neurons and suppress neural excitation by inhibiting metabolic processes in excitatory neurons. This hypothesis is partially supported by our IPA results which indicated a reduction in glutamate receptor signaling (Figure S2B); however, further investigations will be needed to test this hypothesis in the future.
Aside from the knockdown of rpia-1, we also generated strains with rpia-1 overexpression by extrachromosomal array and investigated whether rpia-1 overexpression may negatively affect longevity. By overexpressing rpia-1 under its endogenous promoter, we were able to observe lifespan changes that were specifically attributable to rpia-1 overexpression, without ectopic effects (Figure S5A,B). Overexpression of rpia-1 showed lifespan reduction in worms (Figure S5C,D). Although the outcome matched our expectations, it did not match our previous findings that Rpi overexpression in Drosophila did not affect lifespan [22]. This discrepancy might be due to the difference between the promoters. In our previous study, we overexpressed the coding sequence of Rpi using ubiquitous and pan-neuronal promoters in Drosophila, whereas we overexpressed the genomic sequence of rpia-1 under its own endogenous promoter in this study. Thus, the ectopic expression and the extent of expression levels may be the main factor leading to this difference.
Our experimental results demonstrated a novel molecular mechanism, besides NADPH elevation, involved in rpia-1-mediated longevity effects, that is, the activation of autophagy. The up-regulation of autophagy has been considered beneficial to longevity [10]. Numerous longevity-associated treatments result in increased autophagy, such as caloric restriction, hormetic heat shock, and mitochondrial hormesis [49,65,66]. Moreover, these findings even point out that several longevity-related molecular mechanisms prolong lifespan by activating the AMPK pathway and inhibiting the TOR pathway [67]. The reduction of human RPIA in different cancer cell types, including HeLa cells, pancreatic cancer cells, and lung cancer cells, induces autophagic flux and promotes tumor progression by regulating redox signaling [24,25,68]. Therefore, this evidence prompted us to investigate whether rpia-1-mediated longevity also required the induction of autophagy. Our results confirmed our speculation that autophagy induction is involved in rpia-1 knockdown-mediated lifespan regulation.
As the AMPK and TOR pathways are the major upstream mechanisms regulating autophagy [67] and are associated with cellular energy homeostasis [5], we also wondered if these pathways affected rpia-1 knockdown-mediated longevity. Both our experimental results and RNA-seq analysis suggested that these two pathways were involved in rpia-1 knockdown-mediated longevity. Furthermore, this evidence implied that the AMPK pathway might have the most crucial role in this manipulation. Acting as a kinase in the process of balancing ATP and AMP, the major function of AMPK is to manipulate energy homeostasis. The third enzyme of oxidative phase of PPP (oxiPPP), 6-phosphogluconate dehydrogenase (6-PGD), which can produce ribulose-5-phosphate (Ru-5-P) from 6-phosphogluconate (6-PG), has been shown to inhibit AMPK activity through producing Ru-5-P to disrupt LKB1 complex [69]. The knockdown of the second enzyme of oxiPPP, 6-phosphogluconolactonase (PGLS), increases the generation of the byproduct γ-6-phosphogluconolactone (γ-6PGL), which binds to Src to trigger protein phosphatase 2A (PP2A) recruitment and phosphorylation, and eventually causes AMPK activation [70,71].
According to the evidence above, we proposed that rpia-1 mediates lifespan through two major mechanisms to regulate the activation of the AMPK pathway, that is, the reduction of nucleotide synthesis and the phosphorylation of PP2A (Figure S6) [70]. Previous studies on pancreatic ductal adenocarcinoma have revealed that deregulation of RPIA reduces nucleotide synthesis [72], which triggers activation of the AMPK pathway in response to the low energy status in cells and may benefit longevity [73,74,75]. On the other hand, the deregulation of Rpi in our previous work resulted in the activation of G6PD activity [22], which may increase the production of δ-6PGL. While the δ-6PGL is transformed into a byproduct, γ-6PGL, it induces the phosphorylation of PP2A and eventually leads to AMPK pathway activation. Accompanying the activation of AMPK and the preservation of oxiPPP, the NADPH may accumulate, the TOR pathway may be inhibited, and autophagy flux may be enhanced. Nevertheless, this hypothesis requires more supporting evidence in future experiments which may focus on the role of the intervention of oxiPPP-AMPK in longevity.

5. Conclusions

In sum, our results support that the longevity effects mediated by rpia-1 reduction could be evolutionarily conserved. Not only did the knockdown of rpia-1 enhance oxidative stress tolerance and ameliorate neural polyglutamine toxicity but it also prolonged the lifespan in worms (Figure 8) as well as in flies. Moreover, we also validated the spatial and temporal effects of rpia-1 knockdown in lifespan regulation. That is, knocking down rpia-1 ubiquitously in the post-developmental stage or specifically, in excitatory neurons can both extend lifespan. Additionally, we elucidated the molecular mechanisms crucial for rpia-1 knockdown-mediated lifespan extension, such as the activation of the AMPK pathway and autophagy, or the inhibition of TOR. These findings suggest that rpia-1 knockdown-mediated longevity is an evolutionarily conserved phenomenon, which may indicate that the regulation of rpia-1 can be a potential strategy to improve healthspan and ameliorate aging.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/antiox12010124/s1. Figure S1. CRISPR knockout of rpia-1 mutants did not affect lifespan but resulted in developmental delay. Figure S2. IPA analysis provides biological functions and canonical pathways which are affected by knockdown of rpia-1. Figure S3. IPA analysis provides bio-functions and canonical pathways affected by knockdown of rpia-1. Figure S4. ORA analysis identifies potential down-regulated downstream target genes, which may be involved in rpia-1 knockdown-mediated longevity effect. Figure S5. Overexpression of rpia-1 shortens lifespan. Figure S6. Hypothesis of rpia-1 downregulation mediating longevity through activating AMPK pathway.

Author Contributions

Conceptualization, H.-D.W. and W.-C.S.; methodology, H.-D.W., C.-H.Y., T.-T.C. and W.-C.S.; software, W.-C.S., C.-H.Y. and Y.-T.L.; validation, H.-D.W., W.-C.S., C.-H.Y. and Y.-T.L.; formal analysis, W.-C.S., C.-H.Y. and Y.-T.L.; investigation, W.-C.S., C.-H.Y., Y.-T.L. and Y.-H.L.; resources, W.-C.S., Y.-T.L., T.-T.C. and Y.-H.L.; data curation, W.-C.S. and C.-H.Y.; writing—original draft preparation, W.-C.S.; writing—review and editing, H.-D.W.; visualization, W.-C.S.; supervision, H.-D.W.; project administration, H.-D.W.; funding acquisition, H.-D.W. and C.-Y.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the collaborative project between National Tsing Hua University and Chang Gung University (grant number, 111F7MDSE1), and by National Science and Technology Council (grant numbers, 110-2320-B-007-003 and 111-2320-B-007-006-MY3) to H.-D.W.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The RNA-seq data can be downloaded at the following website: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE216697, with the secure token “gtcdgeagzjitpgb“, accessed on 31 May 2023.

Acknowledgments

We thank the C. elegans Core Facility of the National Core Facility for biopharmaceuticals, National Science and Technology Council, in Taiwan for technical support, and the assistance from Ao-Lin Hsu, Chang-Shi Chen, and Yen-Hung Lin. We thank the technical support from Ya-Hsien Chou at the confocal imaging core at National Tsing Hua University sponsored by NSTC 110-2731-M-007-001.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hofmeister, F.; Baber, L.; Ferrari, U.; Hintze, S.; Jarmusch, S.; Krause, S.; Meinke, P.; Mehaffey, S.; Neuerburg, C.; Tangenelli, F.; et al. Late-onset neuromuscular disorders in the differential diagnosis of sarcopenia. BMC Neurol. 2021, 21, 241. [Google Scholar] [CrossRef] [PubMed]
  2. López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The Hallmarks of Aging. Cell 2013, 153, 1194–1217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Pitt, J.N.; Kaeberlein, M. Why is aging conserved and what can we do about it? PLoS Biol. 2015, 13, e1002131. [Google Scholar] [CrossRef]
  4. Kapahi, P.; Kaeberlein, M.; Hansen, M. Dietary restriction and lifespan: Lessons from invertebrate models. Ageing Res. Rev. 2017, 39, 3–14. [Google Scholar] [CrossRef] [PubMed]
  5. Inoki, K.; Kim, J.; Guan, K.L. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu. Rev. Pharm. Toxicol. 2012, 52, 381–400. [Google Scholar] [CrossRef] [PubMed]
  6. Trefts, E.; Shaw, R.J. AMPK: Restoring metabolic homeostasis over space and time. Mol. Cell 2021, 81, 3677–3690. [Google Scholar] [CrossRef] [PubMed]
  7. Dennis, P.B.; Jaeschke, A.; Saitoh, M.; Fowler, B.; Kozma, S.C.; Thomas, G. Mammalian TOR: A homeostatic ATP sensor. Science 2001, 294, 1102–1105. [Google Scholar] [CrossRef] [PubMed]
  8. Escobar, K.A.; Cole, N.H.; Mermier, C.M.; VanDusseldorp, T.A. Autophagy and aging: Maintaining the proteome through exercise and caloric restriction. Aging Cell 2019, 18, e12876. [Google Scholar] [CrossRef] [Green Version]
  9. Barbosa, M.C.; Grosso, R.A.; Fader, C.M. Hallmarks of Aging: An Autophagic Perspective. Front. Endocrinol. 2019, 9, 790. [Google Scholar] [CrossRef]
  10. Rubinsztein, D.C.; Mariño, G.; Kroemer, G. Autophagy and Aging. Cell 2011, 146, 682–695. [Google Scholar] [CrossRef]
  11. Hansen, M.; Rubinsztein, D.C.; Walker, D.W. Autophagy as a promoter of longevity: Insights from model organisms. Nat. Rev. Mol. Cell Biol. 2018, 19, 579–593. [Google Scholar] [CrossRef] [PubMed]
  12. Kumsta, C.; Chang, J.T.; Lee, R.; Tan, E.P.; Yang, Y.; Loureiro, R.; Choy, E.H.; Lim, S.H.Y.; Saez, I.; Springhorn, A.; et al. The autophagy receptor p62/SQST-1 promotes proteostasis and longevity in C. elegans by inducing autophagy. Nat. Commun. 2019, 10, 5648. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Jones, D.P. Redox theory of aging. Redox Biol. 2015, 5, 71–79. [Google Scholar] [CrossRef] [Green Version]
  14. Go, Y.M.; Jones, D.P. Redox theory of aging: Implications for health and disease. Clin. Sci. 2017, 131, 1669–1688. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Sohal, R.S.; Orr, W.C. The redox stress hypothesis of aging. Free Radic. Biol. Med. 2012, 52, 539–555. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Das, K.; Roychoudhury, A. Reactive oxygen species (ROS) and response of antioxidants as ROS-scavengers during environmental stress in plants. Front. Environ. Sci. 2014, 2, 53. [Google Scholar] [CrossRef] [Green Version]
  17. Omar, H. Mycotoxins-Induced Oxidative Stress and Disease. In Mycotoxin and Food Safety in Developing Countries; InTech: Rijeka, Croatia, 2013; pp. 63–92. [Google Scholar]
  18. Bradshaw, P.C. Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging. Nutrients 2019, 11, 504. [Google Scholar] [CrossRef] [Green Version]
  19. Farkas, R.; Daniš, P.; Medved'ová, L.; Mechler, B.M.; Knopp, J. Regulation of cytosolic malate dehydrogenase by juvenile hormone in Drosophila melanogaster. Cell Biochem. Biophys. 2002, 37, 37–52. [Google Scholar] [CrossRef]
  20. Legan, S.K.; Rebrin, I.; Mockett, R.J.; Radyuk, S.N.; Klichko, V.I.; Sohal, R.S.; Orr, W.C. Overexpression of Glucose-6-phosphate Dehydrogenase Extends the Life Span of Drosophila melanogaster. J. Biol. Chem. 2008, 283, 32492–32499. [Google Scholar] [CrossRef] [Green Version]
  21. Luckinbill, L.S.; Riha, V.; Rhine, S.; Grudzien, T.A. The role of glucose-6-phosphate dehydrogenase in the evolution of longevity in Drosophila melanogaster. Heredity 1990, 65, 29–38. [Google Scholar] [CrossRef]
  22. Wang, C.T.; Chen, Y.C.; Wang, Y.Y.; Huang, M.H.; Yen, T.L.; Li, H.; Liang, C.J.; Sang, T.K.; Ciou, S.C.; Yuh, C.H.; et al. Reduced neuronal expression of ribose-5-phosphate isomerase enhances tolerance to oxidative stress, extends lifespan, and attenuates polyglutamine toxicity in Drosophila. Aging Cell 2012, 11, 93–103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Wang, H.D.; Kazemi-Esfarjani, P.; Benzer, S. Multiple-stress analysis for isolation of Drosophila longevity genes. Proc. Natl. Acad. Sci. USA 2004, 101, 12610–12615. [Google Scholar] [CrossRef] [Green Version]
  24. Heintze, J.; Costa, J.R.; Weber, M.; Ketteler, R. Ribose 5-phosphate isomerase inhibits LC3 processing and basal autophagy. Cell Signal 2016, 28, 1380–1388. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Nieh, Y.C.; Chou, Y.T.; Chou, Y.T.; Wang, C.Y.; Lin, S.X.; Ciou, S.C.; Yuh, C.H.; Wang, H.D. Suppression of Ribose-5-Phosphate Isomerase a Induces ROS to Activate Autophagy, Apoptosis, and Cellular Senescence in Lung Cancer. Int. J. Mol. Sci. 2022, 23, 7883. [Google Scholar] [CrossRef] [PubMed]
  26. Stiernagle, T. Maintenance of C. elegans. In WormBook; Oxford University Press: Oxford, UK, 2006; pp. 1–11. [Google Scholar]
  27. Lin, Y.H.; Chen, Y.C.; Kao, T.Y.; Lin, Y.C.; Hsu, T.E.; Wu, Y.C.; Ja, W.W.; Brummel, T.J.; Kapahi, P.; Yuh, C.H.; et al. Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans. Aging Cell 2014, 13, 755–764. [Google Scholar] [CrossRef] [PubMed]
  28. Conte, D., Jr.; MacNeil, L.T.; Walhout, A.J.M.; Mello, C.C. RNA Interference in Caenorhabditis elegans. Curr. Protoc. Mol. Biol. 2015, 109, 26.3.1–26.3.30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Liu, Y.L.; Lu, W.C.; Brummel, T.J.; Yuh, C.H.; Lin, P.T.; Kao, T.Y.; Li, F.Y.; Liao, P.C.; Benzer, S.; Wang, H.D. Reduced expression of alpha-1,2-mannosidase I extends lifespan in Drosophila melanogaster and Caenorhabditis elegans. Aging Cell 2009, 8, 370–379. [Google Scholar] [CrossRef] [Green Version]
  30. Senchuk, M.M.; Dues, D.J.; Van Raamsdonk, J.M. Measuring Oxidative Stress in Caenorhabditis elegans: Paraquat and Juglone Sensitivity Assays. Bio Protoc. 2017, 7, e2086. [Google Scholar] [CrossRef] [Green Version]
  31. Govindan, J.A.; Jayamani, E.; Zhang, X.; Mylonakis, E.; Ruvkun, G. Dialogue between E. coli free radical pathways and the mitochondria of C. elegans. Proc. Natl. Acad. Sci. USA 2015, 112, 12456–12461. [Google Scholar] [CrossRef] [Green Version]
  32. Corpas, F.J.; Barroso, J.B. NADPH-generating dehydrogenases: Their role in the mechanism of protection against nitro-oxidative stress induced by adverse environmental conditions. Front. Environ. Sci. 2014, 2, 55. [Google Scholar] [CrossRef]
  33. Ju, H.-Q.; Lin, J.-F.; Tian, T.; Xie, D.; Xu, R.-H. NADPH homeostasis in cancer: Functions, mechanisms and therapeutic implications. Signal Transduct. Target. Ther. 2020, 5, 231. [Google Scholar] [CrossRef] [PubMed]
  34. Gkekas, I.; Gioran, A.; Boziki, M.K.; Grigoriadis, N.; Chondrogianni, N.; Petrakis, S. Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases. Antioxidants 2021, 10, 1450. [Google Scholar] [CrossRef] [PubMed]
  35. Bertoni, A.; Giuliano, P.; Galgani, M.; Rotoli, D.; Ulianich, L.; Adornetto, A.; Santillo, M.R.; Porcellini, A.; Avvedimento, V.E. Early and late events induced by polyQ-expanded proteins: Identification of a common pathogenic property of polYQ-expanded proteins. J. Biol. Chem. 2011, 286, 4727–4741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Ajayi, A.; Yu, X.; Lindberg, S.; Langel, Ü.; Ström, A.-L. Expanded ataxin-7 cause toxicity by inducing ROS production from NADPH oxidase complexes in a stable inducible Spinocerebellar ataxia type 7 (SCA7) model. BMC Neurosci. 2012, 13, 86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Brignull, H.R.; Moore, F.E.; Tang, S.J.; Morimoto, R.I. Polyglutamine Proteins at the Pathogenic Threshold Display Neuron-Specific Aggregation in a Pan-Neuronal Caenorhabditis elegans Model. J. Neurosci. 2006, 26, 7597. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. C. elegans Deletion Mutant Consortium. Large-Scale Screening for Targeted Knockouts in the Caenorhabditis elegans Genome. G3 Genes|Genomes|Genet 2012, 2, 1415–1425. [CrossRef] [Green Version]
  39. Muschiol, D.; Schroeder, F.; Traunspurger, W. Life cycle and population growth rate of Caenorhabditis elegans studied by a new method. BMC Ecol. 2009, 9, 14. [Google Scholar] [CrossRef] [Green Version]
  40. Uno, M.; Tani, Y.; Nono, M.; Okabe, E.; Kishimoto, S.; Takahashi, C.; Abe, R.; Kurihara, T.; Nishida, E. Neuronal DAF-16-to-intestinal DAF-16 communication underlies organismal lifespan extension in C. elegans. iScience 2021, 24, 102706. [Google Scholar] [CrossRef]
  41. Schmeisser, S.; Li, S.; Bouchard, B.; Ruiz, M.; Des Rosiers, C.; Roy, R. Muscle-Specific Lipid Hydrolysis Prolongs Lifespan through Global Lipidomic Remodeling. Cell Rep. 2019, 29, 4540–4552. [Google Scholar] [CrossRef] [Green Version]
  42. Filer, D.; Thompson, M.; Takhaveev, V.; Dobson, A.; Kotronaki, I.; Green, J.; Heinemann, M.; Tullet, J.; Alic, N. RNA polymerase III limits longevity downstream of TORC1. Nature 2017, 552, 263–267. [Google Scholar] [CrossRef]
  43. Mallick, A.; Ranawade, A.; van den Berg, W.; Gupta, B.P. Axin-Mediated Regulation of Lifespan and Muscle Health in C. elegans Requires AMPK-FOXO Signaling. iScience 2020, 23, 101843. [Google Scholar] [CrossRef] [PubMed]
  44. Firnhaber, C.; Hammarlund, M. Neuron-specific feeding RNAi in C. elegans and its use in a screen for essential genes required for GABA neuron function. PLoS Genet. 2013, 9, e1003921. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Cai, H. Genetic and Transcriptomic Analysis of Axenic Longevity in Caenorhabditis elegans. Ph.D. Thesis, Ghent University, Ghent, Belgium, 2016. [Google Scholar]
  46. Ewald, C.Y.; Hourihan, J.M.; Bland, M.S.; Obieglo, C.; Katic, I.; Moronetti Mazzeo, L.E.; Alcedo, J.; Blackwell, T.K.; Hynes, N.E. NADPH oxidase-mediated redox signaling promotes oxidative stress resistance and longevity through memo-1 in C. elegans. eLife 2017, 6, e19493. [Google Scholar] [CrossRef] [PubMed]
  47. Spaans, S.; Weusthuis, R.; Van Der Oost, J.; Kengen, S. NADPH-generating systems in bacteria and archaea. Front. Microbiol. 2015, 6, 742. [Google Scholar] [CrossRef]
  48. Wong, S.Q.; Kumar, A.V.; Mills, J.; Lapierre, L.R. Autophagy in aging and longevity. Hum. Genet. 2020, 139, 277–290. [Google Scholar] [CrossRef] [PubMed]
  49. Kumsta, C.; Chang, J.T.; Schmalz, J.; Hansen, M. Hormetic heat stress and HSF-1 induce autophagy to improve survival and proteostasis in C. elegans. Nat. Commun. 2017, 8, 14337. [Google Scholar] [CrossRef] [Green Version]
  50. Klionsky, D.J.; Abdel-Aziz, A.K.; Abdelfatah, S.; Abdellatif, M.; Abdoli, A.; Abel, S.; Abeliovich, H.; Abildgaard, M.H.; Abudu, Y.P.; Acevedo-Arozena, A.; et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy 2021, 17, 1–382. [Google Scholar]
  51. Alers, S.; Löffler, A.S.; Wesselborg, S.; Stork, B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: Cross talk, shortcuts, and feedbacks. Mol. Cell Biol. 2012, 32, 2–11. [Google Scholar] [CrossRef] [Green Version]
  52. González, A.; Hall, M.N.; Lin, S.C.; Hardie, D.G. AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control. Cell Metab. 2020, 31, 472–492. [Google Scholar] [CrossRef]
  53. Kim, W.; Kim, R.; Park, G.; Park, J.-W.; Kim, J.-E. Deficiency of H3K79 histone methyltransferase Dot1-like protein (DOT1L) inhibits cell proliferation. J. Biol. Chem. 2012, 287, 5588–5599. [Google Scholar] [CrossRef] [Green Version]
  54. Karnewar, S.; Neeli, P.K.; Panuganti, D.; Kotagiri, S.; Mallappa, S.; Jain, N.; Jerald, M.K.; Kotamraju, S. Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction. Biochim. Biophys. Acta (BBA)—Mol. Basis Dis. 2018, 1864(Pt. A), 1115–1128. [Google Scholar] [CrossRef] [PubMed]
  55. Heesbeen, H.J.; Oerthel, L.; Vries, P.M.; Wagemans, M.R.J.; Smidt, M.P. Neuronal Dot1l is a broad mitochondrial gene-repressor associated with human brain aging via H3K79 hypermethylation. bioRxiv 2021. [Google Scholar]
  56. Feser, J.; Truong, D.; Das, C.; Carson, J.J.; Kieft, J.; Harkness, T.; Tyler, J.K. Elevated histone expression promotes life span extension. Mol. Cell 2010, 39, 724–735. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Sural, S.; Liang, C.Y.; Wang, F.Y.; Ching, T.T.; Hsu, A.L. HSB-1/HSF-1 pathway modulates histone H4 in mitochondria to control mtDNA transcription and longevity. Sci. Adv. 2020, 6, eaaz4452. [Google Scholar] [CrossRef]
  58. Silva, I.; Lopes, C.; Liz, M. Transthyretin interacts with actin regulators in a Drosophila model of familial amyloid polyneuropathy. Sci. Rep. 2020, 10, 13596. [Google Scholar] [CrossRef]
  59. Chou, Y.T.; Jiang, J.K.; Yang, M.H.; Lu, J.W.; Lin, H.K.; Wang, H.D.; Yuh, C.H. Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating beta-catenin via a novel C-terminal domain. PLoS Biol. 2018, 16, e2003714. [Google Scholar] [CrossRef]
  60. Chou, Y.T.; Chen, L.Y.; Tsai, S.L.; Tu, H.C.; Lu, J.W.; Ciou, S.C.; Wang, H.D.; Yuh, C.H. Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and beta-catenin pathways. Carcinogenesis 2019, 40, 461–473. [Google Scholar] [CrossRef]
  61. Patra, K.C.; Hay, N. The pentose phosphate pathway and cancer. Trends Biochem. Sci. 2014, 39, 347–354. [Google Scholar] [CrossRef] [Green Version]
  62. Andriotis, V.M.E.; Smith, A.M. The plastidial pentose phosphate pathway is essential for postglobular embryo development in Arabidopsis. Proc. Natl. Acad. Sci. USA 2019, 116, 15297–15306. [Google Scholar] [CrossRef] [Green Version]
  63. Dienel, G.A. Brain Glucose Metabolism: Integration of Energetics with Function. Physiol. Rev. 2019, 99, 949–1045. [Google Scholar] [CrossRef]
  64. Zullo, J.M.; Drake, D.; Aron, L.; O’Hern, P.; Dhamne, S.C.; Davidsohn, N.; Mao, C.-A.; Klein, W.H.; Rotenberg, A.; Bennett, D.A.; et al. Regulation of lifespan by neural excitation and REST. Nature 2019, 574, 359–364. [Google Scholar] [CrossRef] [PubMed]
  65. Morselli, E.; Maiuri, M.C.; Markaki, M.; Megalou, E.; Pasparaki, A.; Palikaras, K.; Criollo, A.; Galluzzi, L.; Malik, S.A.; Vitale, I.; et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 2010, 1, e10. [Google Scholar] [CrossRef] [PubMed]
  66. Ristow, M.; Zarse, K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 2010, 45, 410–418. [Google Scholar] [CrossRef] [PubMed]
  67. Kim, J.; Kundu, M.; Viollet, B.; Guan, K.-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 2011, 13, 132–141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Yamamoto, K.; Iwadate, D.; Kato, H.; Nakai, Y.; Tateishi, K.; Fujishiro, M. Targeting autophagy as a therapeutic strategy against pancreatic cancer. J. Gastroenterol. 2022. [Google Scholar] [CrossRef] [PubMed]
  69. Lin, R.; Elf, S.; Shan, C.; Kang, H.B.; Ji, Q.; Zhou, L.; Hitosugi, T.; Zhang, L.; Zhang, S.; Seo, J.H.; et al. 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nat. Cell Biol. 2015, 17, 1484–1496. [Google Scholar] [CrossRef] [Green Version]
  70. Gao, X.; Zhao, L.; Liu, S.; Li, Y.; Xia, S.; Chen, D.; Wang, M.; Wu, S.; Dai, Q.; Vu, H.; et al. γ-6-Phosphogluconolactone, a Byproduct of the Oxidative Pentose Phosphate Pathway, Contributes to AMPK Activation through Inhibition of PP2A. Mol. Cell 2019, 76, 857–871. [Google Scholar]
  71. Dai, C.; Zhang, X.; Xie, D.; Tang, P.; Li, C.; Zuo, Y.; Jiang, B.; Xue, C. Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells. Oncotarget 2017, 8, 95810–95823. [Google Scholar] [CrossRef]
  72. Santana-Codina, N.; Roeth, A.; Zhang, Y.; Yang, A.; Mashadova, O.; Asara, J.; Wang, X.; Bronson, R.; Lyssiotis, C.; Ying, H.; et al. Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. Nat. Commun. 2018, 9, 1–13. [Google Scholar] [CrossRef] [Green Version]
  73. Stenesen, D.; Suh, J.M.; Seo, J.; Yu, K.; Lee, K.S.; Kim, J.S.; Min, K.J.; Graff, J.M. Adenosine nucleotide biosynthesis and AMPK regulate adult life span and mediate the longevity benefit of caloric restriction in flies. Cell Metab. 2013, 17, 101–112. [Google Scholar] [CrossRef] [Green Version]
  74. Asby, D.J.; Cuda, F.; Beyaert, M.; Houghton, F.D.; Cagampang, F.R.; Tavassoli, A. AMPK Activation via Modulation of De Novo Purine Biosynthesis with an Inhibitor of ATIC Homodimerization. Chem. Biol. 2015, 22, 838–848. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Hardie, D.G.; Ross, F.A.; Hawley, S.A. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012, 13, 251–262. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Ubiquitous and pan-neuronal knockdown of rpia-1 increases oxidative stress tolerance and NADPH levels. (A) Whole-life (WL) ubiquitous knockdown of rpia-1 in wild type N2 resulted in 22.3–32.7% increase in mean survival time under 40 mM paraquat treatment compared with the controls (***, p < 0.001, by log-rank test). (B) Quantitative RT-qPCR showed reduced rpia-1 levels (0.6-fold) in worms with whole-life ubiquitous knockdown of rpia-1 (*, p < 0.05, by t-test). (C) Whole-life pan-neuronal knockdown of rpia-1 in TU3401 resulted in a 12.7%–14.5% increase in mean survival time under 40 mM paraquat treatment compared with the controls (***, p < 0.001, by log-rank test). (D) Quantitative RT-qPCR results displayed lowered rpia-1 levels (0.75-fold) in worms with whole-life pan-neuronal knockdown of rpia-1 (***, p < 0.001, by t-test). (E,F) Both whole-life ubiquitous and pan-neuronal knockdown of rpia-1 resulted in a 1.5-fold increase in NADPH levels compared with the controls (*, p < 0.05; **, p < 0.01, by t-test).
Figure 1. Ubiquitous and pan-neuronal knockdown of rpia-1 increases oxidative stress tolerance and NADPH levels. (A) Whole-life (WL) ubiquitous knockdown of rpia-1 in wild type N2 resulted in 22.3–32.7% increase in mean survival time under 40 mM paraquat treatment compared with the controls (***, p < 0.001, by log-rank test). (B) Quantitative RT-qPCR showed reduced rpia-1 levels (0.6-fold) in worms with whole-life ubiquitous knockdown of rpia-1 (*, p < 0.05, by t-test). (C) Whole-life pan-neuronal knockdown of rpia-1 in TU3401 resulted in a 12.7%–14.5% increase in mean survival time under 40 mM paraquat treatment compared with the controls (***, p < 0.001, by log-rank test). (D) Quantitative RT-qPCR results displayed lowered rpia-1 levels (0.75-fold) in worms with whole-life pan-neuronal knockdown of rpia-1 (***, p < 0.001, by t-test). (E,F) Both whole-life ubiquitous and pan-neuronal knockdown of rpia-1 resulted in a 1.5-fold increase in NADPH levels compared with the controls (*, p < 0.05; **, p < 0.01, by t-test).
Antioxidants 12 00124 g001
Figure 2. Knockdown of rpia-1 alleviates polyglutamine toxicity in neurons. (AD) Knockdown of rpia-1 in neuronal polyQ pathogenesis model, AM101, initiated at the whole-life (WL) and at post-developmental stage (Day 0) both reduced puncta area, fluorescence intensity, and puncta count (*, p < 0.05; **, p < 0.01, by t-test). (E) The deteriorated body bending rate due to polyQ aggregation may be alleviated by knockdown of rpia-1 initiated the whole-life (WL) and at post-developmental stage (Day 0) (*, p < 0.05; **, p < 0.01, by t-test and ANOVA).
Figure 2. Knockdown of rpia-1 alleviates polyglutamine toxicity in neurons. (AD) Knockdown of rpia-1 in neuronal polyQ pathogenesis model, AM101, initiated at the whole-life (WL) and at post-developmental stage (Day 0) both reduced puncta area, fluorescence intensity, and puncta count (*, p < 0.05; **, p < 0.01, by t-test). (E) The deteriorated body bending rate due to polyQ aggregation may be alleviated by knockdown of rpia-1 initiated the whole-life (WL) and at post-developmental stage (Day 0) (*, p < 0.05; **, p < 0.01, by t-test and ANOVA).
Antioxidants 12 00124 g002
Figure 3. Knockdown of rpia-1 after developmental stage prolongs lifespan. In these lifespan experiments, solid black line represents the control group, and different blue lines represent the rpia-1 knockdown groups initiate at different time stage. (A) Ubiquitous knockdown of rpia-1 starting at the embryonic stage caused no lifespan extension, whereas (BD) knockdown of rpia-1 after developmental stage at day 0, day 5, and day 7 resulted in 7.5%, 6.5%, and 3.9% in mean lifespan extension, respectively (**, p < 0.01; ***, p < 0.001, by log-rank test). (E) Among the three different time points of onset of rpia-1 knockdown, the knockdown initiated on day 0 resulted in the largest amount of lifespan extension.
Figure 3. Knockdown of rpia-1 after developmental stage prolongs lifespan. In these lifespan experiments, solid black line represents the control group, and different blue lines represent the rpia-1 knockdown groups initiate at different time stage. (A) Ubiquitous knockdown of rpia-1 starting at the embryonic stage caused no lifespan extension, whereas (BD) knockdown of rpia-1 after developmental stage at day 0, day 5, and day 7 resulted in 7.5%, 6.5%, and 3.9% in mean lifespan extension, respectively (**, p < 0.01; ***, p < 0.001, by log-rank test). (E) Among the three different time points of onset of rpia-1 knockdown, the knockdown initiated on day 0 resulted in the largest amount of lifespan extension.
Antioxidants 12 00124 g003
Figure 4. Knockdown of rpia-1 in glutamatergic or cholinergic neurons prolongs lifespan. In these lifespan experiments, all solid black lines represent control group, and blue lines rpia-1 knockdown groups. The solid blue lines indicate rpia-1 knockdown from embryonic stage (WL) and blue dashed lines from day 0 of adulthood. (A) Knockdown of rpia-1 in neurons starting at the embryonic (WL) and post-developmental (Day 0) stages extended the mean lifespan by 13.7% and 5.2%, respectively. (B,C) Knockdown of rpia-1 in muscle or intestine showed no effects on lifespan independent of the time of knockdown initiation (since embryonic (WL) or post-developmental (Day 0) stages). (D) Knockdown of rpia-1 in hypodermis shortened the mean lifespan by 4.6% and 5.1% when initiated at the embryonic or post-developmental stages, respectively. (E) Knockdown of rpia-1 in glutamatergic neurons starting from the embryonic or post-developmental stages extended the mean lifespan by 13.4% and 5.7%, respectively. (F) Knockdown of rpia-1 in cholinergic neurons starting from the embryonic or post-developmental stages extended the mean lifespan by 7% and 7%. (G,H) Knockdown of rpia-1 in GABAergic or dopaminergic neurons did not affect lifespan regardless of the time of knockdown initiation (since embryonic or post-developmental stages).
Figure 4. Knockdown of rpia-1 in glutamatergic or cholinergic neurons prolongs lifespan. In these lifespan experiments, all solid black lines represent control group, and blue lines rpia-1 knockdown groups. The solid blue lines indicate rpia-1 knockdown from embryonic stage (WL) and blue dashed lines from day 0 of adulthood. (A) Knockdown of rpia-1 in neurons starting at the embryonic (WL) and post-developmental (Day 0) stages extended the mean lifespan by 13.7% and 5.2%, respectively. (B,C) Knockdown of rpia-1 in muscle or intestine showed no effects on lifespan independent of the time of knockdown initiation (since embryonic (WL) or post-developmental (Day 0) stages). (D) Knockdown of rpia-1 in hypodermis shortened the mean lifespan by 4.6% and 5.1% when initiated at the embryonic or post-developmental stages, respectively. (E) Knockdown of rpia-1 in glutamatergic neurons starting from the embryonic or post-developmental stages extended the mean lifespan by 13.4% and 5.7%, respectively. (F) Knockdown of rpia-1 in cholinergic neurons starting from the embryonic or post-developmental stages extended the mean lifespan by 7% and 7%. (G,H) Knockdown of rpia-1 in GABAergic or dopaminergic neurons did not affect lifespan regardless of the time of knockdown initiation (since embryonic or post-developmental stages).
Antioxidants 12 00124 g004
Figure 5. Knockdown of rpia-1 prolongs lifespan by inducing autophagy. (A) By conducting qPCR analysis, the transcriptional levels of autophagy-related marker genes lgg-1 and sqst-1 were significantly induced when rpia-1 was ubiquitously reduced (*, p < 0.05; ***, p < 0.001, by t-test). (B) By Western blotting analysis, significantly reduced SQST-1 level and increased LGG-1-II level were detected upon rpia-1 knockdown ubiquitously (*, p < 0.05; ***, p < 0.001, by t-test). (C) (In left panel) Ubiquitous knockdown of rpia-1 from day 0 of adulthood (blue solid line) extended the mean lifespan by 11.6%, whereas the knockdown of lgg-1 from day 0 of adulthood (orange solid line) which suppresses autophagy, ablated the rpia-1 -mediated lifespan extension (green solid line) (***, p < 0.001, by log-rank test). (In right panel) Knockdown efficiency of lgg-1 on lifespan assay was confirmed by lgg-1 knockdown before hormetic heat shock treatment in wild-type N2 strain, which was reported to extend lifespan through the induction of autophagy. Hormetic heat shock treatment prolonged the mean lifespan by 19.2% (black dashed line), but the lifespan extension was ablated by concomitant lgg-1 knockdown (orange dashed line) (***, p < 0.001, by log-rank test).
Figure 5. Knockdown of rpia-1 prolongs lifespan by inducing autophagy. (A) By conducting qPCR analysis, the transcriptional levels of autophagy-related marker genes lgg-1 and sqst-1 were significantly induced when rpia-1 was ubiquitously reduced (*, p < 0.05; ***, p < 0.001, by t-test). (B) By Western blotting analysis, significantly reduced SQST-1 level and increased LGG-1-II level were detected upon rpia-1 knockdown ubiquitously (*, p < 0.05; ***, p < 0.001, by t-test). (C) (In left panel) Ubiquitous knockdown of rpia-1 from day 0 of adulthood (blue solid line) extended the mean lifespan by 11.6%, whereas the knockdown of lgg-1 from day 0 of adulthood (orange solid line) which suppresses autophagy, ablated the rpia-1 -mediated lifespan extension (green solid line) (***, p < 0.001, by log-rank test). (In right panel) Knockdown efficiency of lgg-1 on lifespan assay was confirmed by lgg-1 knockdown before hormetic heat shock treatment in wild-type N2 strain, which was reported to extend lifespan through the induction of autophagy. Hormetic heat shock treatment prolonged the mean lifespan by 19.2% (black dashed line), but the lifespan extension was ablated by concomitant lgg-1 knockdown (orange dashed line) (***, p < 0.001, by log-rank test).
Antioxidants 12 00124 g005
Figure 6. Knockdown of rpia-1 prolongs lifespan through inducing AMPK pathway and reducing TOR pathway. (A) Western blotting results showed that ubiquitous knockdown of rpia-1 starting at post-developmental stage elevated p-AMPK levels, indicating increased AMPK pathway activity (3-fold increase; *, p < 0.05, by t-test). (B) Ubiquitous knockdown of rpia-1 from day 0 of adulthood in wild type N2 strain prolonged the mean lifespan by 6.7% (blue solid line); in contrast, ubiquitous knockdown of rpia-1 in short-lived aak-2 (gt33) strain (black dashed line, −10.7%) failed to induce lifespan extension (blue dashed line). (C) Western blotting results showed that ubiquitous knockdown of rpia-1 starting at post-developmental stage reduced levels of p-S6K, a marker of TOR pathway activity (0.8-fold; *, p < 0.05, by t-test). (D) Ubiquitous knockdown of rpia-1 in wild type N2 strain prolonged the mean lifespan by 11.4% (blue solid line); in contrast, ubiquitous knockdown of rpia-1 in long-lived rsks-1 (ok1255) strain (black dashed line, 7.8%) did not further extend the long-lived lifespan in rsks-1 (ok1255) strain (blue dashed line).
Figure 6. Knockdown of rpia-1 prolongs lifespan through inducing AMPK pathway and reducing TOR pathway. (A) Western blotting results showed that ubiquitous knockdown of rpia-1 starting at post-developmental stage elevated p-AMPK levels, indicating increased AMPK pathway activity (3-fold increase; *, p < 0.05, by t-test). (B) Ubiquitous knockdown of rpia-1 from day 0 of adulthood in wild type N2 strain prolonged the mean lifespan by 6.7% (blue solid line); in contrast, ubiquitous knockdown of rpia-1 in short-lived aak-2 (gt33) strain (black dashed line, −10.7%) failed to induce lifespan extension (blue dashed line). (C) Western blotting results showed that ubiquitous knockdown of rpia-1 starting at post-developmental stage reduced levels of p-S6K, a marker of TOR pathway activity (0.8-fold; *, p < 0.05, by t-test). (D) Ubiquitous knockdown of rpia-1 in wild type N2 strain prolonged the mean lifespan by 11.4% (blue solid line); in contrast, ubiquitous knockdown of rpia-1 in long-lived rsks-1 (ok1255) strain (black dashed line, 7.8%) did not further extend the long-lived lifespan in rsks-1 (ok1255) strain (blue dashed line).
Antioxidants 12 00124 g006
Figure 7. ORA analysis identifies potential up-regulated target genes that may be involved in rpia-1 knockdown-mediated longevity. Before conducting ORA analysis, we set the threshold for change in gene expression levels to two-fold to filter out genes that showed smaller changes in expression. (A) 401 genes were identified as up-regulated in worms with both ubiquitous and pan-neuronal knockdown of rpia-1, and these 401 genes were applied to conduct further ORA analysis by WebGestalt. For (B,C), the data presented are log-transformed p-value (FDR corrected) of GO terms or pathways found to be enriched in the up-regulated gene set. (B) GO term analysis revealed the gene classes with significant changes. The red frames indicate the classes which were specifically found among the up-regulated gene sets. (C) Pathway analyses results including KEGG, Panther, and Reactome. Each pathway enrichment analysis showed the enrichment ratio of the pathway. The bars with darker colors indicated the gene set of pathways was significantly induced. (*, p < 0.05; **, p < 0.01 by Fisher’s exact test). (D) The gene was identified by GO-term analysis. (E) The genes identified by GO-term analysis. In (D,E), blue bars indicate changes in gene expression levels upon ubiquitous rpia-1 knockdown; orange bars indicate those upon pan-neuronal rpia-1 knockdown.
Figure 7. ORA analysis identifies potential up-regulated target genes that may be involved in rpia-1 knockdown-mediated longevity. Before conducting ORA analysis, we set the threshold for change in gene expression levels to two-fold to filter out genes that showed smaller changes in expression. (A) 401 genes were identified as up-regulated in worms with both ubiquitous and pan-neuronal knockdown of rpia-1, and these 401 genes were applied to conduct further ORA analysis by WebGestalt. For (B,C), the data presented are log-transformed p-value (FDR corrected) of GO terms or pathways found to be enriched in the up-regulated gene set. (B) GO term analysis revealed the gene classes with significant changes. The red frames indicate the classes which were specifically found among the up-regulated gene sets. (C) Pathway analyses results including KEGG, Panther, and Reactome. Each pathway enrichment analysis showed the enrichment ratio of the pathway. The bars with darker colors indicated the gene set of pathways was significantly induced. (*, p < 0.05; **, p < 0.01 by Fisher’s exact test). (D) The gene was identified by GO-term analysis. (E) The genes identified by GO-term analysis. In (D,E), blue bars indicate changes in gene expression levels upon ubiquitous rpia-1 knockdown; orange bars indicate those upon pan-neuronal rpia-1 knockdown.
Antioxidants 12 00124 g007
Figure 8. The mechanism of rpia-1-mediated lifespan regulation and oxidative stress response in C. elegans. The down-regulation of rpia-1 results in the elevation of NADPH level, which also benefits oxidative stress tolerance improvement. Moreover, according to previous studies, the elevation of NADPH might benefit the amelioration of aggregated neuronal polyQ implying that rpia-1 reduction-induced neuronal polyQ aggregation alleviation might be attributed to NADPH level. Still, further experiment is required. In addition, rpia-1 reduction positively regulates the AMPK pathway and negatively regulates the TOR pathway, which induces autophagy and eventually leads to lifespan extension in C. elegans. Besides lifespan extension, the neuronal polyQ aggregation might also be alleviated by rpia-1-mediated autophagy induction.
Figure 8. The mechanism of rpia-1-mediated lifespan regulation and oxidative stress response in C. elegans. The down-regulation of rpia-1 results in the elevation of NADPH level, which also benefits oxidative stress tolerance improvement. Moreover, according to previous studies, the elevation of NADPH might benefit the amelioration of aggregated neuronal polyQ implying that rpia-1 reduction-induced neuronal polyQ aggregation alleviation might be attributed to NADPH level. Still, further experiment is required. In addition, rpia-1 reduction positively regulates the AMPK pathway and negatively regulates the TOR pathway, which induces autophagy and eventually leads to lifespan extension in C. elegans. Besides lifespan extension, the neuronal polyQ aggregation might also be alleviated by rpia-1-mediated autophagy induction.
Antioxidants 12 00124 g008
Table 1. Tissue-specific strain information.
Table 1. Tissue-specific strain information.
Strain NameGenotype and DescriptionRegulated Genes/Longevity EffectsReference
TU3401uIs69 [pCFJ90 (myo-2p::mCherry) + unc-119p::sid-1]. Neuron-hypersensitive knockdown line.daf-2↓/lifespan↑; daf-16↓/lifespan↓[40]
WM118neIs9 [myo-3::HA::RDE-1 + rol-6(su1006)]. Muscle-specific knockdown line.kin-1↓/lifespan↑; kin-2↓/lifespan↓[41]
VP303kbIs7 [nhx-2p::rde-1 + rol-6(su1006)]. Intestine-specific knockdown line.rpc-1↓/lifespan↑[42]
NR222kzIs9 [(pKK1260) lin-26p::NLS::GFP + (pKK1253) lin-26p::rde-1 + rol-6(su1006)]. Hypodermis-specific knockdown line.pry-1↓/lifespan↓[43]
Table 2. Neuron cell-type-specific strain information.
Table 2. Neuron cell-type-specific strain information.
Strain NameGenotype and DescriptionRegulated Genes/Longevity EffectsReference
XE1582wpSi11 [eat-4p::rde-1::SL2::sid-1 + Cbr-unc-119(+)] II. Glutamatergic neuron-specific knockdown line.cbp-1↓/lifespan↓[45]
XE1581wpSi10 [unc-17p::rde-1::SL2::sid-1 + Cbr-unc-119(+)] II. Cholinergic neuron-specific knockdown line.
XE1375wpIs36 [unc-47p::mCherry] I. wpSi1 [unc-47p::rde-1::SL2::sid-1 + Cbr-unc-119(+)] II. GABAergic neuron-specific knockdown line.
XE1474wpSi6 [dat-1p::rde-1::SL2::sid-1 + Cbr-unc-119(+)] II. Dopaminergic neuron-specific knockdown line.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shen, W.-C.; Yuh, C.-H.; Lu, Y.-T.; Lin, Y.-H.; Ching, T.-T.; Wang, C.-Y.; Wang, H.-D. Reduced Ribose-5-Phosphate Isomerase A-1 Expression in Specific Neurons and Time Points Promotes Longevity in Caenorhabditis elegans. Antioxidants 2023, 12, 124. https://doi.org/10.3390/antiox12010124

AMA Style

Shen W-C, Yuh C-H, Lu Y-T, Lin Y-H, Ching T-T, Wang C-Y, Wang H-D. Reduced Ribose-5-Phosphate Isomerase A-1 Expression in Specific Neurons and Time Points Promotes Longevity in Caenorhabditis elegans. Antioxidants. 2023; 12(1):124. https://doi.org/10.3390/antiox12010124

Chicago/Turabian Style

Shen, Wen-Chi, Chiou-Hwa Yuh, Yu-Ting Lu, Yen-Hung Lin, Tsui-Ting Ching, Chao-Yung Wang, and Horng-Dar Wang. 2023. "Reduced Ribose-5-Phosphate Isomerase A-1 Expression in Specific Neurons and Time Points Promotes Longevity in Caenorhabditis elegans" Antioxidants 12, no. 1: 124. https://doi.org/10.3390/antiox12010124

APA Style

Shen, W. -C., Yuh, C. -H., Lu, Y. -T., Lin, Y. -H., Ching, T. -T., Wang, C. -Y., & Wang, H. -D. (2023). Reduced Ribose-5-Phosphate Isomerase A-1 Expression in Specific Neurons and Time Points Promotes Longevity in Caenorhabditis elegans. Antioxidants, 12(1), 124. https://doi.org/10.3390/antiox12010124

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop